10:25 AM EST - KP Tissue Inc. : Reports the Q2 2025 financial results of KPT and Kruger Products Inc. Revenue was $536.1 million in Q2 2025 compared to $509.8 million in Q2 2024, an increase of $26.3 million or 5.2%. Adjusted EBITDA was $72.5 million in Q2 2025 compared to $65.3 million in Q2 2024, an increase of 11.0%. Net income was $22.1 million in Q2 2025 compared to $10.6 million in Q2 2024, an increase of $11.5 million. KP Tissue Inc.
shares T.KPT are trading up $0.13 at $9.57.
